Table 1 The formulation of a topical cream used for clinical trials
Classification | Materials | Content (%) |
|---|---|---|
Rhodobacter sphaeroide extracts | Culture medium | 10 |
Water surface region | DI-water | 64.5372 |
EDTA-2NA | 0.018 | |
Glycerin | 3.6 | |
1.3-BG | 1.8 | |
Keltrol-F | 0.045 | |
Thickner I | Carbopol # 940 | 0.09 |
Antiseptic | D-M | 0.18 |
D-P | 0.09 | |
Oil I | Stearic acid | 0.9 |
Kalcol 6870 | 0.9 | |
Kcalcol 8688 | 0.72 | |
GMS 105 | 0.9 | |
Arl 165 | 0.27 | |
Mango buffer | 0.27 | |
Myrj 52s | 1.08 | |
PhytoSqualane | 1.8 | |
CIO | 2.7 | |
Jojoba oil | 2.7 | |
LP 70 | 1.8 | |
DC 200/100CS | 0.45 | |
Phytoshpingosine | 0.135 | |
Cholestrol | 0.45 | |
PC95 | 0.045 | |
Oil II | Borage seed oil | 0.27 |
DC345 | 1.8 | |
Extract | Germall 115 | 0.18 |
Vitamin E acetate | 0.45 | |
Allantoin | 0.09 | |
DL-panthenol | 0.18 | |
Licollice BG 100 | 0.18 | |
SC-glucan | 0.9 | |
Niacinamide | 0.0009 | |
Guava Ext. | 0.0009 | |
KXDUW0028 | 0.162 | |
pH controller | TEA | 0.126 |
Thickner II | Rheocare ATH | 0.18 |